Search results
1 day ago · In Wikidata. An antibiotic is a type of antimicrobial substance active against bacteria. It is the most important type of antibacterial agent for fighting bacterial infections, and antibiotic medications are widely used in the treatment and prevention of such infections. [1] [2] They may either kill or inhibit the growth of bacteria.
May 22, 2024 · Group B streptococcal infection, also known as Group B streptococcal disease or just Group B strep infection, is the infectious disease caused by the bacterium Streptococcus agalactiae, which is the most common human pathogen belonging to the group B of the Lancefield classification of streptococci —hence the group B stretococcal (GBS ...
4 days ago · Methicillin-resistant Staphylococcus aureus (MRSA) is a group of gram-positive bacteria that are genetically distinct from other strains of Staphylococcus aureus. MRSA is responsible for several difficult-to-treat infections in humans.
May 25, 2024 · erythromycin, drug synthesized by the soil bacterium Streptomyces erythraeus and used in the treatment of throat infections, pneumonia, and other diseases. Erythromycin, an antibiotic that inhibits the synthesis of vital proteins in susceptible bacteria, may be either bacteriostatic (i.e., inhibiting bacterial reproduction but not killing ...
- The Editors of Encyclopaedia Britannica
5 days ago · Erythromycin is used to prevent and treat infections in many different parts of the body, including respiratory tract infections, skin infections, diphtheria, intestinal amebiasis, acute pelvic inflammatory disease, Legionnaire's disease, pertussis, and syphilis.
- (67)
May 14, 2024 · Actual Medicinal Product pack (AMPP) - Erythromycin 250mg gastro-resistant tablets (Genesis Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets. Navigation. Pack Size ...
People also ask
Is erythromycin bacteriostatic?
What is Erythromycin used for?
Which diseases are susceptible to erythromycin?
When should I discontinue erythromycin?
May 27, 2024 · Other antibiotics, such as the aminoglycosides, chloramphenicol, erythromycin, and clindamycin, inhibit protein synthesis in bacteria. The basic process by which bacteria and animal cells synthesize proteins is similar, but the proteins involved are different.
